Recap: Arbutus Biopharma Q2 Earnings

Arbutus Biopharma ABUS reported its Q2 earnings results on Thursday, August 4, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Arbutus Biopharma beat estimated earnings by 23.08%, reporting an EPS of $-0.1 versus an estimate of $-0.13.

Revenue was up $11.91 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 0.78% drop in the share price the next day.

Here's a look at Arbutus Biopharma's past performance:

To track all earnings releases for Arbutus Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.